Literature DB >> 15026274

Use of pyrosequencing to detect clinically relevant polymorphisms of genes in basal cell carcinoma.

Zhenzhong Zhang1, Wei Liu, Xin Jia, Yan Gao, Kari Hemminki, Bengt Lindholm.   

Abstract

BACKGROUND: Pyrosequencing is a new method to detect single nucleotide polymorphisms (SNPs). Basal cell carcinoma (BCC) is one of the most common neoplasms in the world, and its incidence has been increasing worldwide in recent years. BCC is caused by an interplay between genetic and environment factors.
METHODS: Pyrosequencing and restrict fragment length polymorphism (RFLP) were used in the study. We conducted a case-control association study in BCC cases and controls from Sweden. For SNPs in IL-6, IL-10 and IL-1beta, 241 cases were at the age of 27-70 years (mean 50 years) and 260 healthy controls were 26-71 years (mean 48 years), 241 cases were 27-70 years (mean 50 years) and 574 healthy controls were 22-74 years (mean 52 years) for cyclin D1 G870A, 197 cases were 29-69 years (mean 47 years) and 574 healthy controls were 22-74 years (mean 52 years) for MTHFR C677T and A1298C. Nine SNPs for IL-6-174G/C, -634G/C and -597G/A; IL-10-1082G/A and -592C/A; IL-1beta-511C/T; cyclin D1 G870A; MTHFR C677T and A1298C were analyzed.
RESULTS: Most genotype distributions were in accordance with Hardy-Weinberg equilibrium (HWE), except IL-10-1082G/A, which had a significantly deviation from HWE in BCC cases (P<0.05). Linkage disequilibrium was observed between the -174 and -597 alleles in the IL-6 gene in the studied populations. The differences for cyclin D1 G870A and methylenetetrahydrofolate reductase (MTHFR) C677T were found between BCC cases group and control group (P<0.05, OR=1.34, 95% CI, 1.00-1.74; P<0.05, OR=1.67, 95% CI, 1.13-2.47, respectively).
CONCLUSIONS: Cyclin D1 G870A and MTHFR C677T were associated with BC cases from Sweden, the other SNPs studied here were not associated with BCC, but chance cannot be excluded.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15026274     DOI: 10.1016/j.cccn.2003.12.010

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  14 in total

1.  IL-6 -174G>C polymorphism and cancer risk: a meta-analysis involving 29,377 cases and 37,739 controls.

Authors:  Bin Xu; Xiao-Bing Niu; Zi-Dun Wang; Wei Cheng; Na Tong; Yuan-Yuan Mi; Zhi-Chao Min; Jun Tao; Peng-Chao Li; Wei Zhang; Hong-Fei Wu; Zheng-Dong Zhang; Zeng-Jun Wang; Li-Xin Hua; Ning-Han Feng; Xin-Ru Wang
Journal:  Mol Biol Rep       Date:  2010-11-23       Impact factor: 2.316

2.  MTHFR (methylenetetrahydrofolate reductase) C677T polymorphism and psoriasis.

Authors:  Vladimir Vasku; Julie Bienertova-Vasku; Miroslav Necas; Anna Vasku
Journal:  Clin Exp Med       Date:  2009-05-30       Impact factor: 3.984

3.  Enhanced skin carcinogenesis and lack of thymus hyperplasia in transgenic mice expressing human cyclin D1b (CCND1b).

Authors:  Paola Rojas; Fernando Benavides; Jorge Blando; Carlos Perez; Kim Cardenas; Ellen Richie; Erik S Knudsen; David G Johnson; Adrian M Senderowicz; Marcelo L Rodriguez-Puebla; Claudio J Conti
Journal:  Mol Carcinog       Date:  2009-06       Impact factor: 4.784

4.  Association study indicates combined effect of interleukin-10 and angiotensin-converting enzyme in basal cell carcinoma development.

Authors:  Nikolaos Koronellos; Christos Yapijakis; Alexandros Katoulis; Dimitris Avgoustidis; Antonis Vylliotis; Veronica Papakosta; Stavroula Diamantopoulou; Omiros Zografos; Georgia Vairaktari; Eleftherios Vairaktaris; Stavros Vassiliou
Journal:  Arch Dermatol Res       Date:  2020-08-08       Impact factor: 3.017

Review 5.  The interleukin 10 -819C/T polymorphism and cancer risk: a HuGE review and meta-analysis of 73 studies including 15,942 cases and 22,336 controls.

Authors:  Zhibin Yu; Qing Liu; Chen Huang; Minghua Wu; Guiyuan Li
Journal:  OMICS       Date:  2013-04

6.  Influence of host interleukin-10 polymorphisms on development of traveler's diarrhea due to heat-labile enterotoxin-producing Escherichia coli in travelers from the United States who are visiting Mexico.

Authors:  Jose Flores; Herbert L DuPont; Stephanie A Lee; Jaime Belkind-Gerson; Mercedes Paredes; Jamal A Mohamed; Lisa Y Armitige; Dong-Chuan Guo; Pablo C Okhuysen
Journal:  Clin Vaccine Immunol       Date:  2008-06-25

7.  The interleukin-10 promoter polymorphism rs1800872 (-592C>A), contributes to cancer susceptibility: meta-analysis of 16,785 cases and 19,713 controls.

Authors:  Qi Ding; Ying Shi; Bo Fan; Zhijiang Fan; Li Ding; Feng Li; Wenjian Tu; Xiaohua Jin; Jing Wang
Journal:  PLoS One       Date:  2013-02-27       Impact factor: 3.240

Review 8.  Systematic review and meta-analysis on the association between IL-1B polymorphisms and cancer risk.

Authors:  Jiali Xu; Zhiqiang Yin; Songyu Cao; Wen Gao; Lingxiang Liu; Yongmei Yin; Ping Liu; Yongqian Shu
Journal:  PLoS One       Date:  2013-05-21       Impact factor: 3.240

9.  Circulating interleukin-6 and cancer: A meta-analysis using Mendelian randomization.

Authors:  Geng Tian; Jia Mi; Xiaodan Wei; Dongmei Zhao; Lingyan Qiao; Chunhua Yang; Xianglin Li; Shuping Zhang; Xuri Li; Bin Wang
Journal:  Sci Rep       Date:  2015-06-22       Impact factor: 4.379

10.  Comparative study and meta-analysis of meta-analysis studies for the correlation of genomic markers with early cancer detection.

Authors:  Zoi Lanara; Efstathia Giannopoulou; Marta Fullen; Evangelos Kostantinopoulos; Jean-Christophe Nebel; Haralabos P Kalofonos; George P Patrinos; Cristiana Pavlidis
Journal:  Hum Genomics       Date:  2013-06-05       Impact factor: 4.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.